DCF — CLEAR LAKE REG MED CTR
Enterprise Value: $391.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$391.9M
Enterprise Value
$99.8M
PV of Cash Flows
$292.1M
PV of Terminal Value
$470.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $633.4M | $53.8M | 9.0% | $17.5M | $15.9M |
| Year 2 | $652.4M | $62.0M | 10.0% | $22.9M | $19.0M |
| Year 3 | $671.9M | $70.6M | 11.0% | $28.7M | $21.5M |
| Year 4 | $692.1M | $76.1M | 11.0% | $32.1M | $21.9M |
| Year 5 | $712.9M | $80.2M | 11.0% | $34.4M | $21.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $391.9M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$614.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000078058847
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5